LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Protein kinase Cδ mutations may contribute to lupus through effects on T cells: comment on the article by Belot et al.

    Richardson, Bruce / Strickland, Faith M / Sawalha, Amr H / Gorelik, Gabriela

    Arthritis & rheumatology (Hoboken, N.J.)

    2014  Volume 66, Issue 1, Page(s) 228–229

    MeSH term(s) Apoptosis ; B-Lymphocytes/pathology ; Female ; Humans ; Lupus Erythematosus, Systemic/enzymology ; Lupus Erythematosus, Systemic/genetics ; Male ; Mutation, Missense ; Protein Kinase C-delta/deficiency ; Protein Kinase C-delta/genetics
    Chemical Substances Protein Kinase C-delta (EC 2.7.11.13)
    Language English
    Publishing date 2014-01
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.38235
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Key role of ERK pathway signaling in lupus.

    Gorelik, Gabriela / Richardson, Bruce

    Autoimmunity

    2009  Volume 43, Issue 1, Page(s) 17–22

    Abstract: Systemic lupus erythematosus is a poorly understood autoimmune disease, characterized by autoantibodies to nuclear antigens and immune complex deposition in organs like the kidney. Current evidence indicates that a pathologic CD4+T cell subset, ... ...

    Abstract Systemic lupus erythematosus is a poorly understood autoimmune disease, characterized by autoantibodies to nuclear antigens and immune complex deposition in organs like the kidney. Current evidence indicates that a pathologic CD4+T cell subset, characterized by impaired extracellular signal-regulated kinase (ERK) pathway signaling, DNA hypomethylation, and consequent aberrant gene expression contributes to disease pathogenesis. Hydralazine is a lupus-inducing drug that also decreases T cell DNA methylation by inhibiting the ERK signaling pathway, replicating the defect found in lupus T cells. These observations suggest that defective ERK pathway signaling alters gene expression in T cells by inhibiting DNA methylation, contributing to lupus pathogenesis. The signaling defect in hydralazine-treated and lupus T cells has now been mapped to protein kinase C delta. Understanding the mechanism causing decreased ERK pathway signaling in lupus may shed light on mechanisms contributing to disease development in genetically predisposed people.
    MeSH term(s) CD4-Positive T-Lymphocytes/enzymology ; CD4-Positive T-Lymphocytes/immunology ; DNA Methylation ; Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Humans ; Lupus Erythematosus, Systemic/enzymology ; Lupus Erythematosus, Systemic/genetics ; Lupus Erythematosus, Systemic/immunology ; MAP Kinase Signaling System ; Protein Kinase C-delta/immunology ; Protein Kinase C-delta/metabolism
    Chemical Substances Protein Kinase C-delta (EC 2.7.11.13) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2009-12-04
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 1025450-x
    ISSN 1607-842X ; 0891-6934
    ISSN (online) 1607-842X
    ISSN 0891-6934
    DOI 10.3109/08916930903374832
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Aberrant T cell ERK pathway signaling and chromatin structure in lupus.

    Gorelik, Gabriela / Richardson, Bruce

    Autoimmunity reviews

    2008  Volume 8, Issue 3, Page(s) 196–198

    Abstract: Human systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibodies to nuclear components with subsequent immune complex formation and deposition in multiple organs. A combination of genetic and environmental factors is ... ...

    Abstract Human systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibodies to nuclear components with subsequent immune complex formation and deposition in multiple organs. A combination of genetic and environmental factors is required for disease development, but how the environment interacts with the immune system in genetically predisposed hosts to cause lupus is unclear. Recent evidence suggests that environmental agents may alter T cell chromatin structure and gene expression through effects on DNA methylation, a repressive epigenetic mechanism promoting chromatin inactivation, to cause lupus in people with the appropriate genetic background. DNA methylation is regulated by ERK pathway signaling, and abnormalities in ERK pathway signaling may contribute to immune dysfunction in lupus through epigenetic effects on gene expression. This article reviews current evidence for epigenetic abnormalities, and in particular DNA demethylation, in the pathogenesis of idiopathic and some forms of drug-induced lupus, and how impaired ERK pathway signaling may contribute to the development of human lupus through effects on T cell DNA methylation.
    MeSH term(s) Animals ; Chromatin/genetics ; Chromatin/metabolism ; Chromatin Assembly and Disassembly/immunology ; DNA Methylation/immunology ; Epigenesis, Genetic/immunology ; Extracellular Signal-Regulated MAP Kinases/immunology ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Genetic Predisposition to Disease ; Humans ; Lupus Erythematosus, Systemic/genetics ; Lupus Erythematosus, Systemic/immunology ; Lupus Erythematosus, Systemic/metabolism ; Mitochondrial Diseases/enzymology ; Mitochondrial Diseases/immunology ; Protein Kinase C/metabolism ; Signal Transduction/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
    Chemical Substances Chromatin ; protein kinase D (EC 2.7.10.-) ; Protein Kinase C (EC 2.7.11.13) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2008-08-22
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2008.07.043
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Oxidative stress, T cell DNA methylation, and lupus.

    Li, YePeng / Gorelik, Gabriela / Strickland, Faith M / Richardson, Bruce C

    Arthritis & rheumatology (Hoboken, N.J.)

    2014  Volume 66, Issue 6, Page(s) 1574–1582

    Abstract: Objective: Lupus develops when genetically predisposed people encounter environmental agents, such as ultraviolet light, silica, infections, and cigarette smoke, that cause oxidative stress, but how oxidative damage modifies the immune system to cause ... ...

    Abstract Objective: Lupus develops when genetically predisposed people encounter environmental agents, such as ultraviolet light, silica, infections, and cigarette smoke, that cause oxidative stress, but how oxidative damage modifies the immune system to cause lupus flares is unknown. We previously showed that inhibiting DNA methylation in CD4+ T cells by blocking ERK pathway signaling is sufficient to alter gene expression, and that the modified cells cause lupus-like autoimmunity in mice. We also reported that T cells from patients with active lupus have decreased ERK pathway signaling, have decreased DNA methylation, and overexpress genes normally suppressed by DNA methylation. This study was undertaken to test whether oxidizing agents decrease ERK pathway signaling in T cells, decrease DNA methyltransferase levels, and cause demethylation and overexpression of T cell genes similar to that found in T cells from patients with active lupus.
    Methods: CD4+ T cells were treated with the oxidizers H2 O2 or ONOO(-) . Effects on ERK pathway signaling were measured by immunoblotting, DNA methyltransferase 1 (DNMT-1) levels were measured by reverse transcriptase-polymerase chain reaction (RT-PCR), and the methylation and expression of T cell genes were measured using flow cytometry, RT-PCR, and bisulfite sequencing.
    Results: H2 O2 and ONOO(-) inhibited ERK pathway signaling in T cells by inhibiting the upstream regulator protein kinase Cδ, decreased DNMT-1 levels, and caused demethylation and overexpression of genes previously shown to be suppressed by DNA methylation in T cells from patients with active lupus.
    Conclusion: Our findings indicate that oxidative stress may contribute to human lupus flares by inhibiting ERK pathway signaling in T cells to decrease DNMT-1 and cause DNA demethylation.
    MeSH term(s) Adult ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/pathology ; Cells, Cultured ; DNA (Cytosine-5-)-Methyltransferase 1 ; DNA (Cytosine-5-)-Methyltransferases/metabolism ; DNA Methylation/drug effects ; DNA Methylation/physiology ; Female ; Humans ; Hydrogen Peroxide/pharmacology ; In Vitro Techniques ; Lupus Erythematosus, Systemic/metabolism ; Lupus Erythematosus, Systemic/pathology ; Lupus Erythematosus, Systemic/physiopathology ; MAP Kinase Signaling System/drug effects ; MAP Kinase Signaling System/physiology ; Male ; Middle Aged ; Oxidative Stress/physiology ; Peroxynitrous Acid/pharmacology ; Protein Kinase C-delta/metabolism
    Chemical Substances Peroxynitrous Acid (14691-52-2) ; Hydrogen Peroxide (BBX060AN9V) ; DNA (Cytosine-5-)-Methyltransferase 1 (EC 2.1.1.37) ; DNA (Cytosine-5-)-Methyltransferases (EC 2.1.1.37) ; Protein Kinase C-delta (EC 2.7.11.13)
    Language English
    Publishing date 2014-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.38427
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice.

    Gorelik, Gabriela / Sawalha, Amr H / Patel, Dipak / Johnson, Kent / Richardson, Bruce

    Clinical immunology (Orlando, Fla.)

    2015  Volume 158, Issue 2, Page(s) 193–203

    Abstract: Genetic and environmental factors contribute to the onset and progression of lupus. CD4+ T cells from patients with active lupus show a decreased ERK signaling pathway, which causes changes in gene expression. The defect points to its upstream regulator, ...

    Abstract Genetic and environmental factors contribute to the onset and progression of lupus. CD4+ T cells from patients with active lupus show a decreased ERK signaling pathway, which causes changes in gene expression. The defect points to its upstream regulator, PKCδ, which exhibits a deficient activity due to oxidative stress. Our aim was to investigate the effect of a defective PKCδ in the development of lupus. We generated a double transgenic C57BL6 × SJL mouse that expresses a doxycycline-induced dominant negative PKCδ (dnPKCδ) in T cells. The transgenic mice displayed decreased T cell ERK signaling, decreased DNMT1 expression and overexpression of methylation sensitive genes involved in the exaggerated immune response in the pathogenesis of lupus. The mice developed anti-dsDNA autoantibodies and glomerulonephritis with IgG deposition. The study indicates common pathogenic mechanisms with human lupus, suggesting that environmentally-mediated T cell PKCδ inactivation plays a causative role in lupus.
    MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; Autoantibodies/metabolism ; Autoimmunity ; DNA (Cytosine-5-)-Methyltransferase 1 ; DNA (Cytosine-5-)-Methyltransferases/genetics ; DNA (Cytosine-5-)-Methyltransferases/metabolism ; Doxycycline/pharmacology ; Extracellular Signal-Regulated MAP Kinases/genetics ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Gene Expression Regulation, Enzymologic/immunology ; Glomerulonephritis/metabolism ; Immunoglobulin G/metabolism ; Lupus Erythematosus, Systemic/immunology ; Mice ; Mice, Transgenic ; Mutation ; Phosphorylation ; Promoter Regions, Genetic ; Protein Kinase C-delta/genetics ; Protein Kinase C-delta/metabolism ; Specific Pathogen-Free Organisms ; T-Lymphocytes/enzymology ; Trans-Activators
    Chemical Substances Anti-Bacterial Agents ; Autoantibodies ; Immunoglobulin G ; Trans-Activators ; DNA (Cytosine-5-)-Methyltransferase 1 (EC 2.1.1.37) ; DNA (Cytosine-5-)-Methyltransferases (EC 2.1.1.37) ; DNMT1 protein, human (EC 2.1.1.37) ; Dnmt1 protein, mouse (EC 2.1.1.37) ; Protein Kinase C-delta (EC 2.7.11.13) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24) ; Doxycycline (N12000U13O)
    Language English
    Publishing date 2015-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2015.03.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Protein kinase Cδ oxidation contributes to ERK inactivation in lupus T cells.

    Gorelik, Gabriela J / Yarlagadda, Sushma / Patel, Dipak R / Richardson, Bruce C

    Arthritis and rheumatism

    2012  Volume 64, Issue 9, Page(s) 2964–2974

    Abstract: Objective: CD4+ T cells from patients with active lupus have impaired ERK pathway signaling that decreases DNA methyltransferase expression, resulting in DNA demethylation, overexpression of immune genes, and autoimmunity. The ERK pathway defect is due ... ...

    Abstract Objective: CD4+ T cells from patients with active lupus have impaired ERK pathway signaling that decreases DNA methyltransferase expression, resulting in DNA demethylation, overexpression of immune genes, and autoimmunity. The ERK pathway defect is due to impaired phosphorylation of T(505) in the protein kinase Cδ (PKCδ) activation loop. However, the mechanisms that prevent PKCδ T(505) phosphorylation in lupus T cells are unknown. Others have reported that oxidative modifications, and nitration in particular, of T cells as well as serum proteins correlate with lupus disease activity. We undertook this study to test our hypothesis that nitration inactivates PKCδ, contributing to impaired ERK pathway signaling in lupus T cells.
    Methods: CD4+ T cells were purified from lupus patients and controls and then stimulated with phorbol myristate acetate (PMA). Signaling protein levels, nitration, and phosphorylation were quantitated by immunoprecipitation and immunoblotting of T cell lysates. Transfections were performed by electroporation.
    Results: Treating CD4+ T cells with peroxynitrite nitrated PKCδ, preventing PKCδ T(505) phosphorylation and inhibiting ERK pathway signaling similar to that observed in lupus T cells. Patients with active lupus had higher nitrated T cell PKCδ levels than did controls, which correlated directly with disease activity, and antinitrotyrosine immunoprecipitations demonstrated that nitrated PKCδ, but not unmodified PKCδ, was refractory to PMA-stimulated T(505) phosphorylation, similar to PKCδ in peroxynitrite-treated cells.
    Conclusion: Oxidative stress causes PKCδ nitration, which prevents its phosphorylation and contributes to the decreased ERK signaling in lupus T cells. These results identify PKCδ as a link between oxidative stress and the T cell epigenetic modifications in lupus.
    MeSH term(s) Adult ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Female ; Humans ; Lupus Erythematosus, Systemic/immunology ; Lupus Erythematosus, Systemic/metabolism ; MAP Kinase Signaling System/physiology ; Male ; Middle Aged ; Oxidative Stress/physiology ; Protein Kinase C-delta/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
    Chemical Substances Protein Kinase C-delta (EC 2.7.11.13) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2012-05-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 127294-9
    ISSN 1529-0131 ; 0004-3591 ; 2326-5191
    ISSN (online) 1529-0131
    ISSN 0004-3591 ; 2326-5191
    DOI 10.1002/art.34503
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Decreased ERK and JNK signaling contribute to gene overexpression in "senescent" CD4+CD28- T cells through epigenetic mechanisms.

    Chen, Yingxuan / Gorelik, Gabriela J / Strickland, Faith M / Richardson, Bruce C

    Journal of leukocyte biology

    2009  Volume 87, Issue 1, Page(s) 137–145

    Abstract: An inflammatory and cytotoxic CD4+CD28- T cell subset infiltrates atherosclerotic plaques and is implicated in plaque rupture and myocardial infarctions. This pathologic subset develops with replicative stress and is found in patients with chronic ... ...

    Abstract An inflammatory and cytotoxic CD4+CD28- T cell subset infiltrates atherosclerotic plaques and is implicated in plaque rupture and myocardial infarctions. This pathologic subset develops with replicative stress and is found in patients with chronic inflammatory diseases such as RA as well as with aging. CD4+CD28- cells overexpress genes normally suppressed by DNA methylation in CD4+CD28+ T cells, such as KIR, perforin, and CD70. How this subset over expresses methylation-sensitive genes is unknown. DNA methylation patterns are maintained in proliferating cells by Dnmts, which are up-regulated during mitosis by the ERK and JNK signaling pathways. We hypothesized that defects in these signaling pathways contribute to altered gene expression in human CD4+CD28- cells through effects on DNA methylation. We report that signaling through the ERK and JNK pathways is decreased in CD4+CD28- relative to CD4+CD28+ cells from the same individuals and that ERK and JNK pathway inhibition decreases Dnmt1 and -3a levels, which in turn, causes demethylation and overexpression of the TNFSF7 (CD70) gene. We also report that CD4+CD28- T cells overexpress PP5, a stress-induced inhibitor of the ERK and JNK signaling pathways that may contribute to the signaling defects. We conclude that decreased ERK and JNK signaling in the CD4+CD28- subset, arising with replicative stress, can lead to the overexpression of normally suppressed genes through effects on Dnmts and consequently, chromatin structure.
    MeSH term(s) Adult ; Aged ; Arthritis, Rheumatoid/immunology ; Arthritis, Rheumatoid/metabolism ; Arthritis, Rheumatoid/pathology ; CD27 Ligand/biosynthesis ; CD27 Ligand/genetics ; CD28 Antigens/analysis ; CD4-Positive T-Lymphocytes/enzymology ; CD4-Positive T-Lymphocytes/metabolism ; Cellular Senescence/physiology ; DNA (Cytosine-5-)-Methyltransferases/metabolism ; DNA Methylation ; Epigenesis, Genetic ; Extracellular Signal-Regulated MAP Kinases/physiology ; Gene Expression Regulation/physiology ; Humans ; JNK Mitogen-Activated Protein Kinases/physiology ; Middle Aged ; Osteoarthritis/immunology ; Osteoarthritis/metabolism ; Osteoarthritis/pathology ; RNA, Small Interfering/pharmacology ; Signal Transduction/genetics ; T-Lymphocyte Subsets/enzymology ; T-Lymphocyte Subsets/metabolism
    Chemical Substances CD27 Ligand ; CD28 Antigens ; CD70 protein, human ; RNA, Small Interfering ; DNA (Cytosine-5-)-Methyltransferases (EC 2.1.1.37) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24) ; JNK Mitogen-Activated Protein Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2009-10-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 605722-6
    ISSN 1938-3673 ; 0741-5400
    ISSN (online) 1938-3673
    ISSN 0741-5400
    DOI 10.1189/jlb.0809562
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus.

    Gorelik, Gabriela / Fang, Jing Yuan / Wu, Ailing / Sawalha, Amr H / Richardson, Bruce

    Journal of immunology (Baltimore, Md. : 1950)

    2007  Volume 179, Issue 8, Page(s) 5553–5563

    Abstract: T cells from patients with lupus or treated with the lupus-inducing drug hydralazine have defective ERK phosphorylation. The reason for the impaired signal transduction is unknown but important to elucidate, because decreased T cell ERK pathway signaling ...

    Abstract T cells from patients with lupus or treated with the lupus-inducing drug hydralazine have defective ERK phosphorylation. The reason for the impaired signal transduction is unknown but important to elucidate, because decreased T cell ERK pathway signaling causes a lupus-like disease in animal models by decreasing DNA methyltransferase expression, leading to DNA hypomethylation and overexpression of methylation-sensitive genes with subsequent autoreactivity and autoimmunity. We therefore analyzed the PMA stimulated ERK pathway phosphorylation cascade in CD4(+) T cells from patients with lupus and in hydralazine-treated cells. The defect in these cells localized to protein kinase C (PKC)delta. Pharmacologic inhibition of PKCdelta or transfection with a dominant negative PKCdelta mutant caused demethylation of the TNFSF7 (CD70) promoter and CD70 overexpression similar to lupus and hydralazine-treated T cells. These results suggest that defective T cell PKCdelta activation may contribute to the development of idiopathic and hydralazine-induced lupus through effects on T cell DNA methylation.
    MeSH term(s) Adult ; Aged ; CD27 Ligand/biosynthesis ; CD27 Ligand/genetics ; Cells, Cultured ; DNA Methylation/drug effects ; Down-Regulation/immunology ; Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Female ; Humans ; Hydralazine/pharmacology ; Lupus Erythematosus, Systemic/chemically induced ; Lupus Erythematosus, Systemic/enzymology ; Lupus Erythematosus, Systemic/immunology ; MAP Kinase Signaling System/drug effects ; MAP Kinase Signaling System/immunology ; Male ; Middle Aged ; Phosphorylation/drug effects ; Promoter Regions, Genetic/drug effects ; Protein Kinase C-delta/antagonists & inhibitors ; Protein Kinase C-delta/metabolism ; Protein Kinase Inhibitors/pharmacology ; T-Lymphocytes/drug effects ; T-Lymphocytes/enzymology ; T-Lymphocytes/metabolism
    Chemical Substances CD27 Ligand ; Protein Kinase Inhibitors ; Hydralazine (26NAK24LS8) ; Protein Kinase C-delta (EC 2.7.11.13) ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2007-09-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.179.8.5553
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-zeta in murine tumor T lymphocytes.

    Barreiro Arcos, María Laura / Gorelik, Gabriela / Klecha, Alicia / Genaro, Ana María / Cremaschi, Graciela A

    American journal of physiology. Cell physiology

    2006  Volume 291, Issue 2, Page(s) C327–36

    Abstract: Regulation of cell proliferation by thyroid hormone (TH) has been demonstrated, but the effect of THs and the mechanisms involved in lymphocyte activity have not been elucidated. Differential expression of PKC isoenzymes and high nitric oxide synthase ( ... ...

    Abstract Regulation of cell proliferation by thyroid hormone (TH) has been demonstrated, but the effect of THs and the mechanisms involved in lymphocyte activity have not been elucidated. Differential expression of PKC isoenzymes and high nitric oxide synthase (NOS) activity have been described in tumor T lymphocytes. We have analyzed the direct actions of TH on normal T lymphocytes and BW5147 T lymphoma cells in relation to PKC and NOS activities. THs increased tumor and mitogen-induced normal T lymphocyte proliferation. PKC isoenzyme-selective blockers impaired these effects in both cell types, indicating the participation of Ca2+-dependent and -independent isoenzymes in normal and tumor cells, respectively. TH actions were blunted by extra- and intracellular Ca2+ blockers only in normal T lymphocytes, whereas NOS blockers impaired TH-induced proliferation in T lymphoma cells. Incubation for 24 h with TH induced a rise in total and membrane-associated PKC activities in both cell types and led to a rapid and transient effect only in tumor cells. THs increased atypical PKC-zeta expression in BW5147 cells and classical PKC isoenzymes in mitogen-stimulated normal T cells. TH augmented NOS activity and inducible NOS protein and gene expression only in tumor cells. Blockade of PKC and the atypical PKC-zeta isoform inhibited TH-mediated stimulation of inducible NOS and cell proliferation. These results show, for the first time, that differential intracellular signals are involved in TH modulation of lymphocyte physiology and pathophysiology.
    MeSH term(s) Animals ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Enzyme Activation/drug effects ; Gene Expression Regulation, Enzymologic/drug effects ; Gene Expression Regulation, Neoplastic/drug effects ; Lymphoma, T-Cell/enzymology ; Mice ; Nitric Oxide Synthase Type II/metabolism ; Protein Kinase C/metabolism ; Thyroid Hormones/administration & dosage
    Chemical Substances Thyroid Hormones ; Nitric Oxide Synthase Type II (EC 1.14.13.39) ; Nos2 protein, mouse (EC 1.14.13.39) ; protein kinase C zeta (EC 2.7.11.1) ; Protein Kinase C (EC 2.7.11.13)
    Language English
    Publishing date 2006-02-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 392098-7
    ISSN 1522-1563 ; 0363-6143
    ISSN (online) 1522-1563
    ISSN 0363-6143
    DOI 10.1152/ajpcell.00316.2005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Overexpression of X-linked genes in T cells from women with lupus.

    Hewagama, Anura / Gorelik, Gabriela / Patel, Dipak / Liyanarachchi, Punsisi / McCune, W Joseph / Somers, Emily / Gonzalez-Rivera, Tania / Strickland, Faith / Richardson, Bruce

    Journal of autoimmunity

    2013  Volume 41, Page(s) 60–71

    Abstract: Women develop lupus more frequently than men and the reason remains incompletely understood. Evidence that men with Klinefelter's Syndrome (XXY) develop lupus at approximately the same rate as women suggests that a second X chromosome contributes. ... ...

    Abstract Women develop lupus more frequently than men and the reason remains incompletely understood. Evidence that men with Klinefelter's Syndrome (XXY) develop lupus at approximately the same rate as women suggests that a second X chromosome contributes. However, since the second X is normally inactivated, how it predisposes to lupus is unclear. DNA methylation contributes to the silencing of one X chromosome in women, and CD4+ T cell DNA demethylation contributes to the development of lupus-like autoimmunity. This suggests that demethylation of genes on the inactive X may predispose women to lupus, and this hypothesis is supported by a report that CD40LG, an immune gene encoded on the X chromosome, demethylates and is overexpressed in T cells from women but not men with lupus. Overexpression of other immune genes on the inactive X may also predispose women to this disease. We therefore compared mRNA and miRNA expression profiles in experimentally demethylated T cells from women and men as well as in T cells from women and men with lupus. T cells from healthy men and women were treated with the DNA methyltransferase inhibitor 5-azacytidine, then X-linked mRNAs were surveyed with oligonucleotide arrays, and X-linked miRNA's surveyed with PCR arrays. CD40LG, CXCR3, OGT, miR-98, let-7f-2*, miR 188-3p, miR-421 and miR-503 were among the genes overexpressed in women relative to men. MiRNA target prediction analyses identified CBL, which downregulates T cell receptor signaling and is decreased in lupus T cells, as a gene targeted by miR-188-3p and miR-98. Transfection with miR-98 and miR-188-3p suppressed CBL expression. The same mRNA and miRNA transcripts were also demethylated and overexpressed in CD4+ T cells from women relative to men with active lupus. Together these results further support a role for X chromosome demethylation in the female predisposition to lupus.
    MeSH term(s) Adult ; Azacitidine/pharmacology ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD40 Ligand/genetics ; CD40 Ligand/immunology ; CD40 Ligand/metabolism ; Cells, Cultured ; DNA Methylation/immunology ; Female ; Genes, X-Linked/genetics ; Genes, X-Linked/immunology ; Humans ; Immunoblotting ; Leukocytes, Mononuclear/drug effects ; Leukocytes, Mononuclear/immunology ; Leukocytes, Mononuclear/metabolism ; Lupus Erythematosus, Systemic/genetics ; Lupus Erythematosus, Systemic/immunology ; Lupus Erythematosus, Systemic/metabolism ; Male ; MicroRNAs/genetics ; MicroRNAs/immunology ; Middle Aged ; N-Acetylglucosaminyltransferases/genetics ; N-Acetylglucosaminyltransferases/immunology ; N-Acetylglucosaminyltransferases/metabolism ; Proto-Oncogene Proteins c-cbl/genetics ; Proto-Oncogene Proteins c-cbl/immunology ; Proto-Oncogene Proteins c-cbl/metabolism ; Receptors, CXCR3/genetics ; Receptors, CXCR3/immunology ; Receptors, CXCR3/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Sex Factors ; Transcriptome/immunology
    Chemical Substances CXCR3 protein, human ; MIRN188 microRNA, human ; MIRN98 microRNA, human ; MicroRNAs ; Receptors, CXCR3 ; CD40 Ligand (147205-72-9) ; Proto-Oncogene Proteins c-cbl (EC 2.3.2.27) ; N-Acetylglucosaminyltransferases (EC 2.4.1.-) ; O-GlcNAc transferase (EC 2.4.1.-) ; CBL protein, human (EC 6.3.2.-) ; Azacitidine (M801H13NRU)
    Language English
    Publishing date 2013-02-19
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 639452-8
    ISSN 1095-9157 ; 0896-8411
    ISSN (online) 1095-9157
    ISSN 0896-8411
    DOI 10.1016/j.jaut.2012.12.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top